Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.20−0.15 (-42.59%)
Close on Nov 13, 2026Market cap $906.90KP/E –Yield –
Oragenics cash
Cash and short-term investments held at the end of each period.
Oragenics's cash was $2.23M at Sep 30, 2026. For fiscal 2025 it was $8.40M, up 871.2% from the year before. Over ten years it grew 5.2% a year on average. The highest annual figure on record is $27.27M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.40M | +871.2% |
| FY2024 | Dec 31, 2024 | $864.84K | -75.2% |
| FY2023 | Dec 31, 2023 | $3.48M | -69.5% |
| FY2022 | Dec 31, 2022 | $11.43M | -58.1% |
| FY2021 | Dec 31, 2021 | $27.27M | +54.6% |
| FY2020 | Dec 31, 2020 | $17.64M | -3.4% |
| FY2019 | Dec 31, 2019 | $18.27M | -9.6% |
| FY2018 | Dec 31, 2018 | $20.21M | +227.7% |
| FY2017 | Dec 31, 2017 | $6.17M | +51.1% |
| FY2016 | Dec 31, 2016 | $4.08M | -19.7% |
| FY2015 | Dec 31, 2015 | $5.08M | -51.4% |
| FY2014 | Dec 31, 2014 | $10.45M | -35.8% |
| FY2013 | Dec 31, 2013 | $16.28M | +64.0% |
| FY2012 | Dec 31, 2012 | $9.93M | +5679.7% |
| FY2011 | Dec 31, 2011 | $171.74K | +30.0% |
| FY2010 | Dec 31, 2010 | $132.10K | -56.2% |
| FY2009 | Dec 31, 2009 | $301.59K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.23M | -80.5% |
| Q2 FY2026 | Jun 30, 2026 | $3.86M | +95.8% |
| Q1 FY2026 | Mar 31, 2026 | $6.11M | +78.5% |
| Q4 FY2025 | Dec 31, 2025 | $8.40M | +871.2% |
| Q3 FY2025 | Sep 30, 2025 | $11.40M | +262.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.97M | +46.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.42M | +65.1% |
| Q4 FY2024 | Dec 31, 2024 | $864.84K | -75.2% |
| Q3 FY2024 | Sep 30, 2024 | $3.14M | -45.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.35M | -79.2% |
| Q1 FY2024 | Mar 31, 2024 | $2.07M | -77.4% |
| Q4 FY2023 | Dec 31, 2023 | $3.48M | -69.5% |
| Q3 FY2023 | Sep 30, 2023 | $5.77M | -58.7% |
| Q2 FY2023 | Jun 30, 2023 | $6.47M | -63.8% |
| Q1 FY2023 | Mar 31, 2023 | $9.16M | -57.1% |
| Q4 FY2022 | Dec 31, 2022 | $11.43M | -58.1% |
| Q3 FY2022 | Sep 30, 2022 | $13.95M | -53.4% |
| Q2 FY2022 | Jun 30, 2022 | $17.87M | -48.3% |
| Q1 FY2022 | Mar 31, 2022 | $21.37M | -41.4% |
| Q4 FY2021 | Dec 31, 2021 | $27.27M | +54.6% |
| Q3 FY2021 | Sep 30, 2021 | $29.95M | +198.2% |
| Q2 FY2021 | Jun 30, 2021 | $34.57M | +259.1% |
| Q1 FY2021 | Mar 31, 2021 | $36.50M | +154.0% |
| Q4 FY2020 | Dec 31, 2020 | $17.64M | -3.4% |
| Q3 FY2020 | Sep 30, 2020 | $10.04M | -54.9% |
| Q2 FY2020 | Jun 30, 2020 | $9.63M | -62.6% |
| Q1 FY2020 | Mar 31, 2020 | $14.37M | -51.0% |
| Q4 FY2019 | Dec 31, 2019 | $18.27M | -9.6% |
| Q3 FY2019 | Sep 30, 2019 | $22.29M | +61.4% |
| Q2 FY2019 | Jun 30, 2019 | $25.72M | +552.7% |
| Q1 FY2019 | Mar 31, 2019 | $29.35M | +516.9% |
| Q4 FY2018 | Dec 31, 2018 | $20.21M | +227.7% |
| Q3 FY2018 | Sep 30, 2018 | $13.81M | +372.4% |
| Q2 FY2018 | Jun 30, 2018 | $3.94M | +88.6% |
| Q1 FY2018 | Mar 31, 2018 | $4.76M | +118.7% |
| Q4 FY2017 | Dec 31, 2017 | $6.17M | +51.1% |
| Q3 FY2017 | Sep 30, 2017 | $2.92M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.09M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.18M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.08M | – |
See a number that looks wrong?